Sign in
4

Changes in Ownership

Beam Therapeutics Inc. Filed Acc 0000899243-20-022630

CEO acquired 115,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Evans John M. CEO 2020-04-16 Option exercise +115,000 $1.03 $118,450 993,257 D
Derivatives
Evans John M. CEO 2020-04-16 Option exercise · Stock Option (Right to Buy) −115,000 402,345 D
Loading xslF345X03/doc4.xml…